Want to see GDRX full AI Analyst Report?
Revenue by Segment
Breaks down earnings by different business areas, revealing which segments drive growth and where the company might face challenges or opportunities.
GoodRx is shifting revenue mix away from a shrinking legacy prescription-transactions business toward rapidly scaling Pharma Direct and recovering subscriptions; Pharma Direct’s surge (82% YoY in Q1 and management now forecasting >50% YoY for 2026) is the primary driver of the raised guidance and stronger EBITDA margins. That mix improvement supports profitable growth, but persistent PTR erosion, flat monthly active users, and potential GLP‑1 price volatility are key execution and pricing risks to monitor.
GDRX Revenue by Segment
| Date | Other | Subscription | Prescription Transactions | Manufacturer Solutions |
|---|---|---|---|---|
| Jun 30, 2026 | $3.88M | $28.51M | $106.39M | $61.63M |
| Mar 31, 2026 | $3.69M | $24.39M | $113.69M | $52.23M |
| Dec 31, 2025 | $4.10M | $21.58M | $124.72M | $44.38M |
| Sep 30, 2025 | $4.64M | $20.72M | $127.29M | $43.37M |
| Jun 30, 2025 | $4.56M | $20.46M | $143.06M | $34.98M |
| Mar 31, 2025 | $4.38M | $21.02M | $148.92M | $28.65M |
| Dec 31, 2024 | $4.83M | $20.68M | $144.99M | $28.09M |
| Sep 30, 2024 | $5.39M | $21.31M | $140.42M | $28.14M |
| Jun 30, 2024 | $5.40M | $22.00M | $146.70M | $26.50M |
| Mar 31, 2024 | $5.40M | $22.60M | $145.40M | $24.50M |
| Dec 31, 2023 | $5.16M | $30.51M | $143.91M | $17.13M |
| Sep 30, 2023 | $5.39M | $15.90M | $135.43M | $23.24M |
| Jun 30, 2023 | $5.00M | $23.90M | $136.50M | $24.30M |
| Mar 31, 2023 | $4.50M | $24.10M | $134.90M | $20.40M |
| Dec 31, 2022 | $5.17M | $24.60M | $129.41M | $24.90M |
| Sep 30, 2022 | $5.15M | $26.45M | $131.22M | $24.50M |
| Jun 30, 2022 | $4.86M | $25.98M | $134.40M | $26.55M |
| Mar 31, 2022 | $5.24M | $19.11M | $155.51M | $23.47M |
| Dec 31, 2021 | $4.80M | $17.40M | $158.79M | $32.30M |
| Sep 30, 2021 | $4.68M | $16.23M | $155.65M | $18.55M |
| Jun 30, 2021 | $4.32M | $14.32M | $144.86M | $13.14M |
| Mar 31, 2021 | $4.99M | $12.01M | $134.06M | $9.37M |
| Dec 31, 2020 | $22.20M | $9.70M | $131.31M | $0.00 |
| Sep 30, 2020 | $16.10M | $7.68M | $124.39M | $0.00 |
| Jun 30, 2020 | $13.70M | $6.36M | $109.55M | $0.00 |
| Mar 31, 2020 | $10.40M | $5.60M | $123.02M | $0.00 |
| Dec 31, 2019 | $8.80M | $0.00 | $104.50M | $0.00 |
| Sep 30, 2019 | $6.00M | $0.00 | $95.80M | $0.00 |
| Jun 30, 2019 | $5.80M | $0.00 | $85.80M | $0.00 |
| Mar 31, 2019 | $3.20M | $0.00 | $78.50M | $0.00 |